Evidence map›Paper›PMID 32279870›Full record

ReviewTuberculosis (Edinburgh, Scotland)2020

The Many Hosts of Mycobacteria 8 (MHM8): A conference report.

Michelle H Larsen, Karen Lacourciere, Tina M Parker, Alison Kraigsley, Jacqueline M Achkar, Linda B Adams, Kathryn M Dupnik, Luanne Hall-Stoodley, Travis Hartman, Carly Kanipe and 5 more

Open access · greenAbstract readReview
In one paragraph

Review in Tuberculosis (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Building Spatiotemporal Understanding ofACS infectious diseases · 2025
    Review
  2. Article
  3. The Many Hosts of Mycobacteria 9 (MHM9): A conference report.Tuberculosis (Edinburgh, Scotland) · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 2 countries.

Michelle H LarsenDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA.
Karen LacourciereNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20892, USA.
Tina M ParkerNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20892, USA.
Alison KraigsleyCenter for Infectious Disease Research and Policy, University of Minnesota, Minneapolis, MN, USA.
Jacqueline M AchkarDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, USA; Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA.
Linda B AdamsDepartment of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, National Hansen's Disease Programs, Baton Rouge, LA, USA.
Kathryn M DupnikCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Luanne Hall-StoodleyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.
Travis HartmanCenter for Global Health, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Carly KanipeDepartment of Immunobiology, Iowa State University, Ames, IA, USA; Oak Ridge Institute for Science and Education, Oak Ridge, TN, USA; Bacterial Diseases of Livestock Research Unit, National Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, USA.
Sherry L KurtzLaboratory of Mucosal Pathogens and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Washington, DC, USA.
Michele A MillerDST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Liliana C M SalvadorDepartment of Infectious Diseases, University of Georgia, Athens, GA, USA; Institute of Bioinformatics, University of Georgia, Athens, GA, USA; Center for the Ecology of Infectious Diseases, University of Georgia, Athens, GA, USA.
John S SpencerDepartment of Microbiology, Immunology, and Pathology, Mycobacteria Research Laboratories, Colorado State University, Fort Collins, CO, USA.
Richard T RobinsonDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA. Electronic address: richard.robinson@osumc.edu.
Albert Einstein College of Medicine · USNational Institutes of Health · USThe Ohio State University · USCenter for Biologics Evaluation and Research · USColorado State University · USCornell University · USNational Animal Disease Center · USNational Hansen's Disease Program · USSouth African Medical Research Council · ZAUniversity of Georgia · USUniversity of Minnesota · USWeill Cornell Medicine · US

Funding

Novel Reporter Phages to Detect Complex TB Drug Resistance and PersistenceR01AI114900 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Michelle H Larsen, Max O'Donnell · 2015 to 2026
$7.2M
Characteristics and protective efficacy of human antibodies against M. tuberculosisR01AI146329 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI ACHKAR, JACQUELINE MICHELE · 2019 to 2023
$3.9M
Host biomarkers for M. tuberculosis infection activity in HIV-infected personsR01AI117927 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ACHKAR, JACQUELINE MICHELE · 2016 to 2020
$3.6M
Regulation of human IL12/IL23 responsiveness by IL12RB1R01AI121212 · NIAID · OHIO STATE UNIVERSITY · PI ROBINSON, RICHARD · 2016 to 2020
$1.9M
Host susceptibility to Mycobacterium tuberculosis recurrence in HIV-infected peopleK23AI131913 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DUPNIK, KATHRYN M · 2018 to 2022
$964k
Antibodies associated with protection against tuberculosis in nonhuman primatesR21AI127173 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ACHKAR, JACQUELINE MICHELE · 2017 to 2018
$473k
NIH Support for Conferences and Scientific MeetingsR13AI145362 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI LARSEN, MICHELLE H · 2019 to 2019
$8k
NIAID NIH HHS K23 AI131913NIAID NIH HHS R01 AI117927NIAID NIH HHS R01 AI121212NIAID NIH HHS R01 AI146329NIAID NIH HHS R13 AI145362NIAID NIH HHS R21 AI127173
6 · The paper itself

Abstract

Mycobacteria are important causes of disease in human and animal hosts. Diseases caused by mycobacteria include leprosy, tuberculosis (TB), nontuberculous mycobacteria (NTM) infections and Buruli Ulcer. To better understand and treat mycobacterial disease, clinicians, veterinarians and scientists use a range of discipline-specific approaches to conduct basic and applied research, including conducting epidemiological surveys, patient studies, wildlife sampling, animal models, genetic studies and computational simulations. To foster the exchange of knowledge and collaboration across disciplines, the Many Hosts of Mycobacteria (MHM) conference series brings together clinical, veterinary and basic scientists who are dedicated to advancing mycobacterial disease research. Started in 2007, the MHM series recently held its 8th conference at the Albert Einstein College of Medicine (Bronx, NY). Here, we review the diseases discussed at MHM8 and summarize the presentations on research advances in leprosy, NTM and Buruli Ulcer, human and animal TB, mycobacterial disease comorbidities, mycobacterial genetics and 'omics, and animal models. A mouse models workshop, which was held immediately after MHM8, is also summarized. In addition to being a resource for those who were unable to attend MHM8, we anticipate this review will provide a benchmark to gauge the progress of future research concerning mycobacteria and their many hosts.

Indexed as

BacteriologyBiomedical ResearchInfectious Disease MedicineAnimalsCongresses as TopicDiffusion of InnovationDisease Models, AnimalHost-Pathogen InteractionsHumansMycobacteriumMycobacterium Infections, NontuberculousTuberculosis

Identifiers

PMID32279870
PMCPMC7428850
OpenAlexW3006056705

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.